Ex-GW Pharma bosses lead development of new CBD-based epilepsy drug

6 months ago

Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical bosses on board.  The clinical stage biopharma company, formerly known as Sapient Therapeutics, announced its new name, meaning ‘to unlock’, in a press release on Monday 13 May, as it progresses towards FDA approval of its […]